To view this notification widget you need to have JavaScript enabled. This notification widget was easily created with NotifySnack.
  Loading... Please wait...

Blog - Pirfenidone

Why You Should Find Alternatives To The Pulmonary Fibrosis Drug Pirfenidone

Posted by

Idiopathic pulmonary fibrosis is the scarring of the lung tissue that leads to decreased lung function and eventually death. Doctors do not know what causes the onset of idiopathic pulmonary fibrosis and it can progress at varying rates among different patients. Ultimately, the only cure for idiopathic pulmonary fibrosis is a lung transplant. This procedure is only feasible for younger patients who have been diagnosed with this disease.

Clinical Treatments

There are various treatments that are used to address the symptoms of idiopathic pulmonary fibrosis. These include oxygen therapies and drugs such as prednisone that reduce inflammation. While these drugs can improve quality of life while living with the disease, they cannot eliminate it. There is a relatively new drug on the market that was approved by the FDA last year called pirfenidone. Pirfenidone works by inhibiting the build up of fibrin or scar tissue on the lungs. This is one of the first drugs to address the root problem associated of idiopathic pulmonary fibrosis.

The Latest Trends

This may sound like good news, however the positive effects of the drug are rather minuscule and they still only slow the progression of the disease rather than stop it. MedScape discusses a clinical trial performed with the drug. The results of the trial were published in the New England Journal of Medicine in 2014. While the results of the trials statistically demonstrated a slower rate of decline, it did not demonstrate a better rate of survival. The improvements in the quality of life were so small that patients did not necessarily notice them. Dr. Hunninghake, a professor at Harvard Medical School, was quoted saying, Its difficult when we have a drug that improves the outcome for patients but they can't perceive that. Ultimately, we want to see more than this.

In addition to the minuscule improvements from taking pirfenidone, there were common side effects. The most common side effects were skin rash and gastrointestinal problems.

It is disappointing when the only drug treating the root problem associated with idiopathic pulmonary fibrosis is barely effective. However, there are safe alternatives that treat the underlying problem of scar tissue associated with pulmonary fibrosis.

Healthy Alternatives

Serrapeptase is an systemic enzyme that works throughout the body to dissolve excess fibrin. Fibrin is hardened dead tissue. This enzyme was originally used by silkworms to eat away at their cocoons without causing damage to any living tissue. These enzymes work in the same way in the body eating away at dead scar tissue without harming living, healthy tissue. Serrapeptase not only slows the progression of idiopathic pulmonary fibrosis, but also can eat away at existing fibrin on the lungs, effectively reversing the disease.

Biomedic Labs RX has two products, Serracor-NK and Serra RX 80, that have incorporated serrapeptase into a blend of enzymes, herbs and minerals, that eat away at fibrin, reduce inflammation, reduce mucus and promote healthy immune system response. These systemic enzymes are enterically coated so they survive the environment in the stomach and are absorbed into the body through the small intestine. All of these attributes work together to fight the progression of pulmonary fibrosis and help you feel better as well.

The best news is that these systemic enzymes are safe and do not have any adverse side effects. Using serrapeptase works with your body to reverse the scar tissue forming on the lungs.

Take control of your treatment and talk with your doctor about trying Serracor-NK and Serra RX80 as an alternative and/or in conjunction to pirfenidone. You may find you experience better outcomes than using clinical medications.

Image: ”Pills 1” by e-magine art

View Comments